Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 19.54B | 19.01B | 17.77B | 7.61B | 3.82B |
Gross Profit | 5.59B | 5.96B | 3.03B | -198.60M | -1.51B |
EBITDA | 5.71B | 5.62B | 5.17B | 1.42B | -2.43B |
Net Income | 2.78B | 2.67B | 2.16B | -962.00M | -4.27B |
Balance Sheet | |||||
Total Assets | 43.09B | 44.26B | 50.19B | 49.72B | 37.58B |
Cash, Cash Equivalents and Short-Term Investments | 8.78B | 12.66B | 16.73B | 14.17B | 8.05B |
Total Debt | 12.91B | 13.45B | 15.34B | 15.92B | 14.34B |
Total Liabilities | 27.02B | 27.52B | 29.94B | 26.92B | 21.30B |
Stockholders Equity | 15.66B | 16.34B | 19.86B | 22.41B | 15.91B |
Cash Flow | |||||
Free Cash Flow | 2.83B | 3.73B | 7.47B | -289.20M | -6.21B |
Operating Cash Flow | 4.71B | 5.05B | 9.15B | 2.83B | -3.44B |
Investing Cash Flow | -3.30B | -1.44B | -490.10M | -2.32B | -1.40B |
Financing Cash Flow | -4.33B | -8.78B | -5.88B | 5.44B | 9.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $26.52B | 7.31 | 33.57% | ― | 5.31% | 35.95% | |
78 Outperform | $32.99B | 8.96 | 27.52% | 1.19% | 4.91% | -27.21% | |
77 Outperform | $16.85B | 8.36 | 17.47% | 5.33% | 3.30% | 4.36% | |
73 Outperform | $30.64B | 18.73 | 22.41% | 1.57% | 3.12% | -13.82% | |
68 Neutral | $19.36B | 40.35 | 5.63% | 2.12% | 3.26% | 27.77% | |
65 Neutral | $10.75B | 15.72 | 5.20% | 1.90% | 3.09% | -27.42% | |
64 Neutral | $7.64B | 13.25 | -21.27% | ― | 1.92% | 36.07% |